Genmab — September 2020
-
God morgen.
-
Daratumumab (anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with anti-IFN-γ autoantibodies https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1086/5880009
-
I noted Genmab is looking for an Infectious Diseases Scientist and that there is something called "Genmab Infectious Disease initiative" https://genmab.wd3.myworkdayjobs.com/en-US/Genmab_Careers_Site/job/Utrecht/Scientist--Infectious-Diseases_R414
-
Faldt lidt tilfældigt over denne gamle nyhed, som jeg ikke havde hørt om før: Tavotek Biotherapeutics Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab’s Proprietary DuoBody
Technology Platform against a Pair of Disease Relevant Targets -
Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab's DuoBody® Platform against a Pair of Disease Relevant Targets
/PRNewswire/ -- Tavotek Biotherapeutics, a biotech company which develops novel biologics for autoimmune diseases and oncology, announced that it has entered...
(www.prnewswire.com)
-
God morgen
-
God morgen.
-
-
Large new ECOG-ACRIN trial, Dara Len Dex, adding Bortezomib in the consolidation phase only https://clinicaltrials.gov/ct2/show/NCT04566328?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Teprotumumab+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+duobody&lupd_s=09%2F28%2F2020&draw=2&rank=3
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind